Diagnosis and management of children and adult craniopharyngiomas: a French Endocrine Society/French Society for Paediatric Endocrinology & Diabetes Consensus Statement T Cuny, R Reynaud, G Raverot, R Coutant, P Chanson, D Kariyawasam, ... Annales d'Endocrinologie, 2024 | | 2024 |
Letter to the editor from Salle et al.:“A prospective multicenter observational study of surgical versus non-surgical management for pituitary apoplexy” L Salle, G Raverot, H Salle The Journal of Clinical Endocrinology & Metabolism 109 (7), e1555-e1556, 2024 | 1 | 2024 |
Corrigendum to" Pneumocystis pneumoniae in patients with Cushing's syndrome: A French multicentric retrospective study. Annales d'Endocinologie 84 (2022) 37-44]" A Lugat, H Lasolle, M François, N Benhenda, L Bricaire, E Cornu, ... Annales d'endocrinologie, S0003-4266 (24) 00056-8, 2024 | | 2024 |
Evidence for somatic mutation screening on aggressive prolactinomas M Theodoropoulou, S Petersenn, P Chanson, G Raverot Nature Reviews Endocrinology, 1-2, 2024 | | 2024 |
Gonadotropic status in adult women with pituitary stalk interruption syndrome A Terray, B Baussart, M Zins, M Goldberg, S Kab, L Cazabat, M Briere, ... European Journal of Endocrinology, lvae064, 2024 | | 2024 |
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine MR Gadelha, A Casagrande, CJ Strasburger, M Bidlingmaier, PJ Snyder, ... The Journal of Clinical Endocrinology & Metabolism, dgae385, 2024 | 1 | 2024 |
Long-term safety and efficacy of subcutaneous pasireotide in patients with cushing F Bogazzi, S Cannavo, C Giordano, M Detomas, C Scaroni, G Raverot, ... Endocrine Abstracts 99, 2024 | | 2024 |
Deciphering microenvironment interactions during age-related pituitary tumour onset and through orthotopic mouse pre-clinical model A Flores-Martinez, M Chanal, M Daura, A Vasiljevic, R Bolbos, ... Endocrine Abstracts 99, 2024 | | 2024 |
Mast cells, a new actor in gonadotroph tumors MD Ilie, M Lepetit, M Chanal, A Vasiljevic, E Jouanneau, O Gandrillon, ... Endocrine Abstracts 99, 2024 | | 2024 |
B-RAF and MEK inhibitor argeted therapy in papillary craniopharyngiomas: results from the French national multicenter study AD De, G Gkasdaris, C Briet, F Almairac, J Boetto, C Mouly, ... Endocrine Abstracts 99, 2024 | | 2024 |
Gonadotroph pituitary tumors: not always nonfunctioning A Carretti, IM Diana, A Vasiljevic, ML Jaffrain-Rea, E Jouanneau, ... Endocrine Abstracts 99, 2024 | | 2024 |
Results of systematic KDM1A genotyping in a large series of Primary Bilateral Macronodular Adrenal Hyperplasia (PBMAH) patients and analysis of the genotype/phenotype correlation L Bouys, A Vaczlavik, P Vaduva, A Jouinot, F Violon, A Berthon, ... Endocrine Abstracts 99, 2024 | | 2024 |
Constitutional duplication of PRKACA gene is a cause of isolated primary pigmented nodular adrenocortical disease (PPNAD) P Vaduva, F Violon, G Raverot, E Stephanie, A Attia, L Bouys, ... Endocrine Abstracts 99, 2024 | | 2024 |
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial B Gatta-Cherifi, K Mohammedi, T Cariou, C Poitou, P Touraine, G Raverot, ... European Journal of Endocrinology 190 (4), 257-265, 2024 | 3 | 2024 |
A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis KKY Ho, M Fleseriu, J Wass, L Katznelson, G Raverot, AS Little, ... The Lancet Diabetes & Endocrinology 12 (3), 209-214, 2024 | 4 | 2024 |
Hypogonadotropic hypogonadism: Never forget iron E Dybal, G Raverot, AB de la Perrière Annales d'endocrinologie 85 (1), 92-93, 2024 | | 2024 |
Carney complex predisposes to breast cancer: prospective study of 50 women P Vaduva, F Violon, A Jouinot, L Bouys, S Espiard, F Bonnet-Serrano, ... European Journal of Endocrinology 190 (2), 121-129, 2024 | | 2024 |
Pituitary apoplexy score, toward standardized decision-making: a descriptive study H Salle, M Cane, M Rocher, E Auditeau, MP Teissier, G Raverot, L Salle Pituitary 27 (1), 77-87, 2024 | 4 | 2024 |
Minerva Endocrinology 2024 Jan 19 D DE ALCUBIERRE, AL CARRETTI, F DUCRAY, E JOUANNEAU, ... Minerva 19, 2024 | | 2024 |
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide. AL Carretti, F Ducray, E Jouanneau, G Raverot, MD Ilie Minerva Endocrinology, 2024 | 2 | 2024 |